Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bijing Xiao

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Immunopharmacology|August 3, 2023
Baseline and early changes in the neutrophil-lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapyHui Ouyang, Bijing Xiao, Yan Huang, et al.
Cancer Immunology, Immunotherapy : CII|August 17, 2023
Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysisBijing Xiao, Hui Ouyang, Haimiti Gulizeba, et al.
Journal of Translational Medicine|May 10, 2024
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferationBijing Xiao, Guanjun Li, Haimiti Gulizeba, et al.
Journal of Thoracic Disease|August 5, 2022
Sarcopenia defined by skeletal muscle mass index at the third lumbar vertebra is a prognostic factor for extensive-stage small cell lung cancer patients: a retrospective studyKai Wang, Wen Long, Xiaoxian Sima, et al.
Journal of Translational Medicine|May 21, 2024
Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancersHong Liu, Xiaoxian Sima, Bijing Xiao, et al.
Medcomm|November 10, 2025
First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-AnalysisWei Du, Anlin Li, Bijing Xiao, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
Tertiary lymphoid structures gene signature predicts response to immunotherapy plus chemotherapy in advanced non-small cell lung cancerWei Du, Bijing Xiao, Xuan Yang, et al.
International Journal of Cancer|May 5, 2026
Skeletal Muscle Metastasis in Patients With SMARCA4-Deficient Thoracic Tumors: A Retrospective Cohort StudyXueyuan Chen, Mengting Shi, Yuwen Yang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Immunopharmacology|August 3, 2023
Baseline and early changes in the neutrophil-lymphocyte ratio (NLR) predict survival outcomes in advanced colorectal cancer patients treated with immunotherapyHui Ouyang, Bijing Xiao, Yan Huang, et al.
Cancer Immunology, Immunotherapy : CII|August 17, 2023
Nomogram for predicting the prognosis of metastatic colorectal cancer patients treated with anti-PD1 therapy based on serum lipids analysisBijing Xiao, Hui Ouyang, Haimiti Gulizeba, et al.
Journal of Translational Medicine|May 10, 2024
Choline metabolism reprogramming mediates an immunosuppressive microenvironment in non-small cell lung cancer (NSCLC) by promoting tumor-associated macrophage functional polarization and endothelial cell proliferationBijing Xiao, Guanjun Li, Haimiti Gulizeba, et al.
Journal of Thoracic Disease|August 5, 2022
Sarcopenia defined by skeletal muscle mass index at the third lumbar vertebra is a prognostic factor for extensive-stage small cell lung cancer patients: a retrospective studyKai Wang, Wen Long, Xiaoxian Sima, et al.
Journal of Translational Medicine|May 21, 2024
Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancersHong Liu, Xiaoxian Sima, Bijing Xiao, et al.
Medcomm|November 10, 2025
First-Line Third-Generation EGFR Tyrosine Kinase Inhibitor Monotherapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-AnalysisWei Du, Anlin Li, Bijing Xiao, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
Tertiary lymphoid structures gene signature predicts response to immunotherapy plus chemotherapy in advanced non-small cell lung cancerWei Du, Bijing Xiao, Xuan Yang, et al.
International Journal of Cancer|May 5, 2026
Skeletal Muscle Metastasis in Patients With SMARCA4-Deficient Thoracic Tumors: A Retrospective Cohort StudyXueyuan Chen, Mengting Shi, Yuwen Yang, et al.
Pageof 1